# Lesinurad Tablet Relative Bioavailability

> **NCT01986556** · PHASE1 · COMPLETED · sponsor: **Ardea Biosciences, Inc.** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Lesinurad 400 mg (Site 1)
- **DRUG:** Lesinurad 400 mg (Site 2, Lot A)
- **DRUG:** Lesinurad 400 mg (Site 2, Lot B)

## Key facts

- **NCT ID:** NCT01986556
- **Lead sponsor:** Ardea Biosciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2014-04
- **Final completion:** 2014-05
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2014-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01986556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01986556, "Lesinurad Tablet Relative Bioavailability". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01986556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*